| Absorption |
| Blood-Brain Barrier | BBB- | 0.7747 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2- | 0.7890 |
| P-glycoprotein Substrate | Substrate | 0.8066 |
| P-glycoprotein Inhibitor | Inhibitor | 0.5464 |
| Inhibitor | 0.7632 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8036 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5146 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6553 |
| CYP450 2D6 Substrate | Substrate | 0.5735 |
| CYP450 3A4 Substrate | Substrate | 0.6922 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8575 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.5229 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8850 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8634 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.9088 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5146 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8723 |
| Inhibitor | 0.7789 |
| AMES Toxicity | Non AMES toxic | 0.5828 |
| Carcinogens | Non-carcinogens | 0.5444 |
| Fish Toxicity | High FHMT | 0.9500 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9036 |
| Honey Bee Toxicity | Low HBT | 0.6801 |
| Biodegradation | Not ready biodegradable | 0.8434 |
| Acute Oral Toxicity | III | 0.5232 |
| Carcinogenicity (Three-class) | Non-required | 0.5944 |